Justin Parker Neurological Institute1155 Alpine Avenue, Suite 320Boulder, Colorado 80304303-938-5700www.bnasurg.com

FACULTY AND SPEAKERSB

OU

LDER

NEU

RO

SUR

GIC

AL

ASS

OC

IATE

S 11

55 A

LPIN

E A

VE S

TE 3

20

BO

ULD

ER C

O 8

0304

-993

9

NO

PO

STAG

EN

ECES

SAR

YIF

MAI

LED

IN T

HE

UN

ITED

STA

TES

ZIP

CO

DE

FOR

LET

TER

SIZ

E BR

M O

NLY

Art

wor

k is

not

dra

wn

to th

e sp

ecifi

catio

ns

of y

our p

artic

ular

mai

lpie

ce.

Plea

se a

djus

t ac

cord

ing

to y

our m

ailp

iece

.

BUSI

NES

S R

EPLY

MAI

LFI

RST

-CLA

SS M

AIL

BOU

LDER

, CO

PER

MIT

NO

. 106

POST

AGE

WIL

L BE

PAI

D B

Y AD

DR

ESSE

E

7th Annual Symposium

Current Techniques in the Treatment of Cranial and Spinal DisordersA concise review encompassing the rapid evolution and innovations in neurosurgical and orthopedic spine technology, advancements in minimally invasive spine surgery, skull base tumors and cerebrovascular neurosurgery.

Saturday, September 11th, 2010

The Omni Interlocken Resort Broomfield, Colorado

Jointly Sponsored by AANS in Conjunction with JPNI and BNA

Lee Nelson, MD Dr. Nelson received his MD from Baylor College of Medicine and Texas Medical Center in Houston. He has extensive training in the treatment of spinal trauma from the Ben Taub General Hospital. Dr. Nelson also underwent training in the renowned M.D. Anderson Cancer Center in surgical and non-surgical management of spinal oncology.

Alexander Mason, MD Dr. Mason received his MD from Ohio State University College of Medicine and Public Health, completed his residency at the Cleveland Clinic Foundation with interests in complex and mini-mally invasive spine, neuro-oncology and surgical epilepsy. His fellowship was in cerebrovascular and skull base surgery at Emory University.

Alan Zacharias, MD Dr. Zacharias received his MD from the Univer-sity of Mississippi. His neurology residency was completed at the University of Virginia followed by a neuromuscular and EMG fellowship at Emory University. He has been in private practice since 2000. He practices neurology with special interest in neuromuscular diseases and EMG.

Sharad Rajpal, MD Dr. Rajpal received his MD and neurosurgery train-ing at the University of Wisconsin. He completed a combined orthopedic and neurological surgery spine fellowship at the nationally renowned Cleveland Clinic where he gained experience in the latest techniques in spinal oncology, minimal access surgery and complex spinal deformity.

Greg Arends, MD Dr. Arends specializes in diagnostic and therapeutic spinal injections and interventional techniques. He received his MD from the Wayne State University School of Medicine and completed his residency in physical medicine and rehabilitation at North-western University. He completed his fellowship in interventional spine at Emory University.

Sanjay Misra, MD Dr. Misra is an Australian neurosurgeon and spine surgeon. During his career he has taught, done fellowships and been on the faculty at universities in Arkansas, Sydney, Colorado and Texas. Dr. Misra is an advisor for various national regulatory institutions and instructor for the American College of Surgeons.

Pete Reusswig, MD Dr. Reusswig received his MD from the New York Medical College in Valhalla and completed his residency in anesthesia at the UCLA Medical Center. Dr. Reusswig is the founder and President of Colorado Pain Management, P.C., Director of Anesthesiology at the Musculoskeletal Surgery Center, in Thornton, CO, and Medical Director of the Pain Center at Vibra Hospital.

Ed Arenson, MD Dr. Arenson received his MD from the Hahnemann Medical College and completed his residency in pediatrics at the University of Colorado Health Sci-ences Center. Dr. Arenson is currently the Medical Director of the Center for Brain and Spinal Tumors, Director of Neuro-oncology, and past President of the Medical Advisory Board at the Colorado Neuro-logical Institute (CNI).

T I T A N I U M L E V E L

AFTERNOON SESSION

MORNING SESSION

7:30 Continental Breakfast/Exhibition Alan T. Villavicencio, MD Introduction and Welcome by the Program Chairman

5:00 Adjournment and Closing Remarks Alan T. Villavicencio, MD Refreshments and Dinner

8:00 Interesting Neurology and Neurosurgery Cases Alan Zacharias, MD8:30 Current Trends in Spinal Cord Stimulation Pete Reusswig, MD9:00 Pain Control Following Spine Surgery: A Multi-Modality Approach Sharad Rajpal, MD

9:30 Coffee Break /Exhibition

12:15 Lunch/Exhibition

3:30 Coffee Break /Exhibition

10:00 Individualized Patient Approach to High Grade Gliomas Ed Arenson, MD10:30 Minimally Invasive Approaches to Skull Base Tumors Kevin O. Lillehei, MD11:15 Advances in Cerebrovascular Neurosurgery Alexander Mason, MD11:45 Ask the Experts Panel 1

1:15 Extreme Lateral Approaches to the Spine Lee Nelson, MD1:45 Advancements in Minimally Invasive Spine Surgery Daniel Sciubba, MD2:30 Spinal Deformity: The Good, the Bad and the Ugly Alan T. Villavicencio, MD3:00 Ask the Experts Panel 2

4:00 Human Engineering Sanjay Misra, MD4:30 Tactical Field Medicine for SWAT Teams Greg Arends, MD

B R O N Z E E X H I B I T O R S

S I L V E R L E V E L

G O L D L E V E L

P L A T I N U M L E V E L

DISTINGUISHED VISITING PROFESSORS

PROGRAM AND LEARNING OBJECTIVES 2010 PROGRAM SCHEDULE

Dr. Villavicencio graduated from Harvard Medical School in Boston, MA in 1995 and completed a neurosurgical residency at Duke University and specialty orthopedic spine surgery fellowship at Cedars-Sinai Medical Center. He is one of only a handful of surgeons in the country with dual neurosurgery and orthopedic spine training.

Dr. Villavicencio is the Founder and Chairman of the Board for the Justin Parker Neurological Institute. Dr. Villavicencio published more than 60 peer-reviewed articles and book chapters and presented hundreds of abstracts at national and international neurosurgical meetings. Dr. Villavicencio is the principle investigator for several ongoing U.S. Food and Drug Administration (FDA) IDE (Investigational Device Exemption) prospective randomized trials.

Alan T. Villavicencio, MD

Kevin O. Lillehei, MD Dr. Lillehei went to Medical School at the University of Minnesota and completed his residency in neurosurgery at the University of Michigan. He is Professor and Director of the Neuro-Oncology Program in the Department of Neurosurgery at the University of Colorado Health Sciences Center. Dr. Lillehei is Director of the Neurosurgery-Neuro-Oncology laboratory with his research interests in malignant gliomas. In particular, he is interested in studying the role

of the immune system in intracranial tumor recognition and irradication, and is exploring the use of various tumor vaccines as adjuvant therapy for the treatment of malignant gliomas.

Daniel Sciubba, MD Dr. Sciubba received his MD from Columbia University College of Physicians and Surgeons. He completed his residency in neurosurgery and complex spine fellowship under Dr. Ziya Gokaslan at The Johns Hopkins Hospital. He also conducted a traveling spine fellowship in pediatric spine deformity under Drs. Randall Betz and Amer Samdani. Dr. Sciubba is an Assistant Professor of Neurosurgery, Oncology and Orthopaedic Surgery at Johns Hopkins

Univeristy, with research interests that focus on developing new treatment options for the management of spine tumors, biomechanically evaluating novel spine instrumentation constructs, and assessing the efficacy of surgical and medical therapeutics for spinal pathology.

T H A N K S T O O U R S U P P O R T E R S

Phon

e: S

end

this

car

d in

and

cal

l 303

-938

-570

0 w

ith c

redi

t car

d in

form

atio

n.M

ail:

S

end

this

car

d in

with

a c

heck

to:

Just

in P

arke

r Neu

rolo

gica

l Ins

titu

te

Att

n: S

ympo

sium

201

0

115

5 A

lpin

e Av

enue

, Sui

te 3

20

Bou

lder

, CO

803

04

HO

W T

O R

EGIS

TER:

For a

dditi

onal

info

rmat

ion

plea

se v

isit

ww

w.b

nasu

rg.c

om. O

n si

te re

gist

ratio

n w

ill b

e av

aila

ble,

but

not

gua

rant

eed.

Bef

ore

Sept

embe

r 3rd

, 201

0 ❏

$50

(sem

inar

, bre

akfa

st, l

unch

) ❏

+$2

5 (c

ockt

ails

, din

ner)

Aft

er S

epte

mbe

r 3rd

, 201

0❏

$60

(sem

inar

, bre

akfa

st, l

unch

)❏

+$2

5 (c

ockt

ails

, din

ner)

Curr

ent T

echn

ique

s in

the

Trea

tmen

t of C

rani

al a

nd S

pina

l Dis

orde

rs

Satu

rday

, Sep

tem

ber 1

1, 2

010,

The

Om

ni In

terl

ocke

n Re

sort

, Br

oom

field

, Col

orad

o

Nam

e:D

egre

e:

M

D

D

O

D

C

O

ther

:

Inst

itutio

n:

Addr

ess:

City

:St

ate:

Zip

Code

:

Emai

l:Te

l:Fa

x:

Spec

ialty

:

Dear Colleague:

We would like to extend this invitation to the upcoming symposium Current Techniques in the Treatment of Cranial and Spinal Disorders, which is organized by Justin Parker Neurological Institute (JPNI) and Boulder Neurosurgical Associates (BNA). This meeting is a one-day intensive live presentation educational seminar for anyone involved in the care of neurosurgical or orthopaedic spine patients. This includes surgeons, primary care physicians, interventional physiatrists, chiropractors, physician assistants, nurse practitioners, physical therapists, and anyone interested in the subject. The most innovative technologies and the latest evidence-based clinical guidelines in the care of cranial and spinal disorders will be presented.

Upon completion of this program, participants should be able to:

• Describe a number of new treatments and innovative technologies that are available for the management of spinal and cranial disorders • Discuss recommendations for treatment of spinal and cranial disorders based on the latest evidence-based clinical practice guidelines • Discuss basic recommendations relevant to clinical practice and to the improvement of patient outcomes

We are looking forward to seeing you at the meeting.

Alan T. Villavicencio, MD Program Chairman

CME Credit - This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the AANS and JPNI. The AANS is accredited by the ACCME to provide continuing medical education for physicians. The AANS designates this educational activity for a maximum of 7 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure - In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), anyone in a position to control the content of the educational activity (speakers, paper presenters/authors, co-authors, staff, and the significant others of those mentioned), are required to disclose any relationship they have with commercial interests which may be related to the content of their lecture. Failure or refusal to disclose or the inability to satisfactorily resolve the identified conflict may result in the withdrawal of the invitation to participate in any AANS education activities. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. The ACCME defines a “commercial interest” as any entity producing marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients. Disclosures will be published in the meeting program/handouts.